记者获悉，全球光学与光电领域巨头蔡司近日在上海外高桥保税区正式启动大中华区总部综合园区建设 项目。新园区规划建设用地面积超5万平方米，是蔡司迄今为止在华规模最大的单笔基础设施投资。蔡 司大中华区总裁兼首席执行官费铭远（Martin Fischer）也表示，在政府持续扩大开放、营商环境不断优 化的背景下，蔡司的业务实现快速增长，本土化成就不断推进。"'十五五'开局之际，蔡司大中华区总 部综合园区正式启动建设，我们将以更快的速度、更高的质量提升本土服务能力，深度融入中国创新生 态，助力中国市场实现高质量与可持续发展。"（智通财经） ...

蔡司大中华区总裁兼首席执行官费铭远（Martin Fischer） 来源：美通社 上海2026年2月7日 /美通社/ -- 作为光学与光电领域的全球领先科技企业，蔡司在上海外高桥保税区正式 启动大中华区总部综合园区建设项目。新园区规划建设用地面积超5万平方米，是蔡司迄今为止在华规 模最大的单笔基础设施投资。新园区建成后，将整合并升级蔡司大中华区总部的管理、运营、销售、研 发、生产、供应链等核心职能，全面提升本地运营与协同能力。蔡司也将进一步增强在华创新研发能 力，把新园区打造成为蔡司全球创新网络的关键枢纽。建设新园区是蔡司在华本土化发展的全新里程 碑，标志着蔡司在浦东、在上海进一步深植根基，持续深化对中国市场的长期承诺。 蔡司集团总裁兼首席执行官裴安德（Andreas Pecher）先生表示："今年恰逢蔡司成立180周年和'蔡司 2030战略'开启，在追求韧性与增长的道路上，蔡司将继续在全球范围内深化本地布局。中国是蔡司最 大、最具活力的市场之一，而上海立足中国经济发展的前沿，为全球企业提供了广阔的发展空间，期待 新园区成为驱动蔡司全球创新与业务增长的能量引擎，也为中国经济的高质量发展注入强劲而持久的科 创动 ...

浦东新区新闻办供图 2月7日，蔡司大中华区总部综合园区建设启动仪式在外高桥保税区举行。这是蔡司迄今为止在华规模最大的单笔基础设施投资，表明其看好中国、扎根上 海、加码浦东发展的坚定信心。 上海市委常委、浦东新区区委书记、中国（上海）自由贸易试验区管委会主任李政出席启动仪式。 在中国市场的经营历史上，外高桥保税区一直是蔡司重要的战略锚点。蔡司集团总裁兼首席执行官裴安德（Andreas Pecher）介绍，从1999年立足外高桥开 拓中国市场以来，中国已成长为蔡司全球最大、最具创新活力的市场。仅在过去10年里，蔡司在中国的营收就翻了6倍，对上海的税收贡献也增长了4倍，这 是此次进一步扩大投资的基础。 按照规划，园区还将衔接蔡司长三角、粤港澳大湾区整体创新布局，持续强化在华研发实力。 "中国是蔡司最大、最具活力的市场之一，而上海立足中国经济发展的前沿，为全球企业提供了广阔的发展空间，期待新园区成为驱动蔡司全球创新与业务 增长的能量引擎，也为中国经济的高质量发展注入科创动能。"裴安德说。 蔡司是光学与光电领域的全球领先科技企业，创立于1846年，总部位于德国奥伯科亨。建设新园区是蔡司在华本土化发展的全新里程碑。新园区 ...

2月7日，全球光学与光电技术领先企业蔡司在上海外高桥保税区正式启动大中华区总部综合园区建设项目。新园区规划建设用地面积超5万平方米，是 蔡司迄今为止在华规模最大的单笔基础设施投资。 据悉，新园区建成后，将整合并升级蔡司大中华区总部的管理、运营、销售、研发、生产、供应链等核心职能，全面提升本地运营与协同能力。蔡司也 将进一步增强在华创新研发能力，把新园区打造成为蔡司全球创新网络的关键枢纽。 公开资料显示，蔡司集团于1846年在德国成立，如今在全球约50个国家拥有约46600名员工，致力于光学和光电领域的技术创新。在2024/25财年，蔡司 集团全年营收近120亿欧元，覆盖工业质量与研究、医疗技术、光学消费品市场、半导体制造技术四大业务板块，目前，集团收入的15%用于科学和研发。 早在1957年，蔡司便进入中国市场，1999年作为贸易公司入驻外高桥保税区，后于2013年升级为大中华区管理总部，并在2020年加入上海自贸区首 批"全球营运商计划 (GOP）"，进一步提高了全球资源配置能力，推动了总部职能的升级。 值得一提的是，今年是"十五五"规划的开局之年，而蔡司也在今年开启了新一轮的全球五年战略，即"蔡司2030 ...

Core Insights - Zeiss has been participating in the China International Import Expo (CIIE) for eight consecutive years, marking its 68th year in China, highlighting the significance of the number "8" in Chinese culture [1][2] - The company is increasing its investment and presence in China, launching a comprehensive headquarters project to integrate operations, sales, R&D, production, and supply chain functions [1][5] Investment and Market Strategy - Zeiss views China as an ideal business destination due to its large market, open business environment, favorable policies, abundant talent and resources, and developed supply chain [1][5] - The company has experienced a sixfold revenue growth in the past decade, with over 7,000 employees in China, and has been recognized as a "Top Employer" for six consecutive years [6][6] Innovation and Product Development - At the CIIE, Zeiss showcased over 60 innovative solutions across four business areas: medical technology, consumer optics, industrial quality and research, and semiconductor manufacturing technology [2][4] - Notable product launches included the ARTEVO 750 digital navigation surgical microscope, which features a 21% improvement in optical resolution, and the PENTERO 800 S, the first high-end surgical microscope developed in China [4][5] Collaboration and Local Integration - Zeiss is deepening its integration into the local ecosystem by establishing R&D centers in Shanghai, Suzhou, and Guangzhou, and has obtained 89 patents in China [7][8] - The company is forming strategic partnerships with local firms, such as SF Express and vivo, to enhance its supply chain ecosystem and accelerate innovation [8][8] Future Outlook - The new comprehensive headquarters project is Zeiss's largest single investment in China, aimed at enhancing service capabilities and acting as a global innovation center [6][6] - The company is committed to supporting China's "Healthy China 2030" initiative through its medical and vision care solutions, aligning its technological advantages with China's strategic goals [6][6]

Core Insights - Zeiss has showcased its commitment to innovation and collaboration in China by participating in the China International Import Expo for the eighth consecutive year, emphasizing its strategy of "Innovating Together" [1][3][11] - The company aims to deepen its integration into China's innovation ecosystem, signing a memorandum of understanding with the Shanghai Technology Entrepreneurship Center to actively participate in technological development in Shanghai and the Yangtze River Delta region [1][11][13] Group 1: Strategic Focus - Zeiss's participation in the expo is themed "Leading the Frontier, New Chapter," highlighting its leadership, investment commitment, innovative technology, and local integration [3][5] - The CEO of Zeiss Greater China, Martin Fischer, expressed optimism about the opportunities presented by the expo, stating that it allows the company to enhance social welfare through technological strength and support high-quality development across various industries in China [3][5] Group 2: Innovation Ecosystem - The roundtable forum discussed the construction of an open and win-win innovation ecosystem, with a focus on collaboration with local customers and partners [5][10] - The company plans to foster talent through a "production-education integration" model, accelerating the incubation and implementation of innovative technologies [5][10] Group 3: Collaboration with Academia - Experts from Shanghai institutions emphasized the importance of collaboration between industry, academia, and research to accelerate the transformation of scientific achievements [7][8] - Zeiss's advanced microscopy equipment has been recognized for meeting cutting-edge research needs, with recent breakthroughs in imaging precision and reliability from locally manufactured products [10][11] Group 4: Healthcare Initiatives - Zeiss is committed to enhancing healthcare accessibility in China, aligning with the "Healthy China 2030" initiative by integrating global optical technology with local clinical needs [11] - The company aims to create a "medical-engineering integration" loop to drive product iteration based on clinical demands, contributing to the high-quality development of China's healthcare sector [11][13]

Core Insights - The article highlights the increasing trend of foreign companies, particularly Zeiss, deepening localization and R&D investments in China despite global economic uncertainties and geopolitical tensions [1][4][9] Group 1: Localization and Investment - Zeiss has established a manufacturing and R&D base in Suzhou, which has seen its revenue double to 760 million RMB within a year, becoming the largest microscope factory globally [2][4] - The Suzhou facility has successfully localized the production of three high-end microscope models, marking Zeiss as the first international manufacturer to achieve this in the laser confocal and field emission scanning electron microscope sectors [2][4] - The commitment to localization is evident as Zeiss chose to purchase land for factory construction rather than leasing, indicating a long-term strategy in China [4][5] Group 2: Market Dynamics and Competitive Landscape - China is recognized as Zeiss's largest market globally, with growth rates leading the world, which directly influences the company's global performance [4][5] - The local supply chain in China is robust, providing a competitive edge for high-end manufacturing, which Zeiss leverages to enhance its product offerings [5][6] - The competition from local suppliers is viewed positively, as it drives technological advancements across the industry [5][6] Group 3: Quality and Standards - The quality control standards in China are reportedly more stringent than in Germany, with local customers often preferring products manufactured in China for their reliability [8][6] - The localization of high-end production is seen as a continuous process, with key production steps being transferred to China to reduce costs and improve market familiarity [6][8] Group 4: Broader Foreign Investment Trends - Despite a decline in actual foreign direct investment (FDI) globally, many foreign companies, including Bosch, are committing to significant investments in China, with Bosch planning to invest over 3 billion RMB in R&D over the next six years [9][10] - Surveys indicate a strong willingness among German and American companies to continue investing in China, with many considering it a top investment destination [10]